Strains and preparations · United Kingdom

Prices — what is published

No UK clinic or pharmacy publishes a product-level price list without a patient login — clinic medication lists may not be displayed openly (Human Medicines Regulations 2012). What operators publish openly are entry prices per form; the price of a named product is in the clinic's formulary after registration.

What the register does not record

The most important limit is what dm+d does NOT contain. As of the 3 September 2026 data, dm+d holds no cannabis flower and no full-spectrum cannabis oil products at all: there is no VMP linked to the ingredient Delta-9-tetrahydrocannabinol ('There are currently no VMPs for this Ingredient'), no VTM for cannabis, and no AMP whose name or supplier matches Bedrocan, Bediol, Bedica, Bedrolite, Pedanios, Aurora, Adven, Curaleaf, Khiron, Althea, Tilray, Spectrum, Cellen, Little Green Pharma, 4C Labs, Grow Pharma, Noidecs, Target Healthcare or IPS. The unlicensed cannabis-based products for medicinal use (CBPMs) that UK private clinics prescribe therefore have no dm+d entry and no dm+d SNOMED code, and cannot be listed on a dm+d-anchored catalogue. What dm+d does hold is narrower: the three licensed cannabinoid medicines (Sativex, Epidyolex, nabilone) together with their discontinued predecessors and wholesaler-labelled versions, one 'Special Order' unlicensed cannabidiol oral solution, three 'Special Order' unlicensed nabilone strengths, one unlicensed dronabinol import from the United States, and the pre-licence Epidiolex entries. Presence in dm+d proves only that NHSBSA has assigned an identifier to a product description so that it can be coded on NHS systems; it does not prove that the product is currently manufactured, stocked, imported, prescribed, reimbursed, or lawful to promote. A 'Special Order' AMP is a generic placeholder for an unlicensed special obtained from any manufacturer or importer and names no supplier. 'Discontinued' and 'Invalid' are dm+d's own flags and are reproduced as found; absence of a flag does not mean the product is available. dm+d does not record marketing-authorisation numbers, so licence numbers appear only where the MHRA SmPC was read on 7 September 2026; for the other MHRA-licensed nabilone AMPs (Meda, Cambridge Laboratories, Valeant, A A H, Alliance Healthcare) the licence number could not be tied to the dm+d record with certainty and is left empty. THC/CBD figures are given only where dm+d states a strength in the product name; cannabis extract composition of Sativex beyond its dm+d VMP strength is not reproduced. Nothing here is a statement about efficacy, indication, or suitability for any patient.

Beneath the flower: the 9 importers and manufacturers the MHRA licenses

Every cannabis flower and full-spectrum oil prescribed privately in the UK is an unlicensed special with no product-level record anywhere. What can be checked is the company: it must hold an MHRA manufacturer's (specials) licence or wholesale dealer's licence, and those registers are public. This is that layer — the licence number, what it covers, and the product families each supplier names on its own site. Names only: no strengths, no effects, no prices, because no public document backs them.

1. 4C LABS

   4C Labs Ltd · Companies House 13894984

   Anchored to: MHRA MS 56289 · UK WDA(H) 56289

   MS: Importation only (2.1). Site: Victoria Square, Victoria Street, St Albans AL1 3TF · WDA(H): Annex 1: medicinal products without a UK authorisation intended for the UK market (1.2); procurement (2.1), supply (2.3); narcotic or psychotropic products (3.1.1); POM (4.1)

   Product families, as the supplier names them: Pure Sunfarms (Pink Kush, Jet Fuel Gelato, D. Burger) · The Green Organic Dutchman (Organic Maple Kush, Organic Cherry Mints, Organic Gold Butter Mac) · Fraser Valley (Blue Dream) · Qwest (BB, PSC, GCC)

   Product names copied from the supplier's products page; no potency figures recorded. Organigram announced a supply agreement with 4C LABS for the UK on 15 Aug 2023 (Organigram products not listed on the 4C products page at check time). Companies House also shows a UK branch registration (BR024546) of the Canadian parent.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

2. Cantourage UK

   Cantourage UK Limited · Companies House 13145673

   Anchored to: MHRA UK WDA(H) 54893 · Home Office controlled-drug licence stated by the company

   WDA(H): Annex 1: medicinal products without a UK authorisation, both intended (1.2) and not intended (1.3) for the UK market; procurement, supply, export (2.1, 2.3, 2.4); products imported from countries on a list (2.6); narcotic or psychotropic products (3.1.1); POM (4.1)

   Product families, as the supplier names them: Cantourage EU-GMP dried flower and extract products (own press release, 13 Apr 2022)

   Press release (13 Apr 2022) states Cantourage UK received an MHRA WDA(H) (10 Dec 2021) and a 'Home Office narcotics license under the Misuse of Drugs Regulations 2001'. The UK site describes a 'curated Tier-1 formulary' from partner cultivators but names no individual brands. No MS licence found.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

3. Curaleaf Laboratories (Rokshaw)

   Rokshaw Limited (trading as Curaleaf Laboratories / Curaleaf Pharmacy) · Companies House 08154114

   Anchored to: MHRA MS 41467 · UK WDA(H) 41467

   MS: Non-sterile products: capsules (hard shell), liquids for external and internal use, other solid dosage forms, semi-solids, suppositories; manufacture of herbal products (1.4.1.1); primary packing incl. tablets; secondary packing; QC chemical/physical testing; importation (2.1). Site: Unit 7 East Way, Rivergreen Industrial Estate, Sunderland SR4 6AD · WDA(H): Annex 1: medicinal products with and without a UK authorisation (1.1, 1.2); procurement, holding, supply, export (2.1–2.4); products imported from countries on a list (2.6); narcotic or psychotropic products (3.1.1); cold chain (3.3); POM, GSL, P categories (4.1, 4.2, 4.4)

   Product families, as the supplier names them: Curaleaf Oil [FS] (named in MHRA Class 2 recall EL(26)A/13, 12 Mar 2026, issued to 'Rokshaw Limited Trading as Curaleaf Laboratories', MS 41467)

   The MHRA recall notice is the only checkable document tying a named product family to this MS licence; it is cited for the name only, not for the recall content. 'Adven' is Curaleaf International's European brand (patient leaflets on curaleafinternational.com); no UK document naming Adven's UK importer was found, so Adven is not attributed here.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

4. GROW Pharma / GROW Group UK

   Grow Group UK Limited · Companies House 06009025

   Anchored to: MHRA MS 34777 · UK MIA(IMP) 34777 · UK WDA(H) 34777

   MS: Non-sterile capsules (hard shell), liquids for external and internal use, other solid dosage forms, semi-solids, suppositories; manufacture of herbal products (1.4.1.1); primary and secondary packing; importation (2.1). Site: NTU Medical Technologies Innovation Facility, First Avenue, Beeston, Nottingham NG9 1BG; contract labs BCM, Lucideon, Prime Labs · MIA(IMP): Manufacturer's/importer's authorisation for investigational medicinal products (legal basis: Investigational) · WDA(H): Annex 1: medicinal products with and without a UK authorisation (1.1, 1.2); procurement, holding, supply, export (2.1–2.4); products imported from countries on a list (2.6); narcotic or psychotropic products (3.1.1); cold chain (3.3); POM, GSL, P categories (4.1, 4.2, 4.4)

   Product families, as the supplier names them: GROW medications (own range — 'we also supply our own range of GROW medications') · Tilray medical cannabis products (import/distribution agreement announced 9 Feb 2021) · SOMAÍ Pharmaceuticals portfolio (UK distribution announced 12 Mar 2024 via 'Grow Pharma, the UK joint venture of Grow Group PLC and Vertical Pharma Resources Ltd t/a IPS Pharma')

   Own site: 'GROW are the UK's largest suppliers of quality prescribed cannabis medicines'. Companies House shows the company in a Voluntary Arrangement (CVA). Third-party sources describe Grow Pharma as UK distributor of Bedrocan; Bedrocan's own site does not name a UK importer, so Bedrocan is not attributed here. No Home Office licence statement found on the site.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

5. Hilltop Leaf

   Hilltop Leaf Ltd · Companies House 12638808

   Anchored to: MHRA MS 54236 · UK WDA(H) 54236 · Home Office controlled-drug licence stated by the company

   MS: Importation only (2.1). Site: Craig Coome, Westerkirk, Langholm DG13 0NZ; contract lab ARC Pharma (UK) Limited · WDA(H): Annex 1: medicinal products without a UK authorisation intended for the UK market (1.2); procurement, holding, supply, export (2.1–2.4); products imported from countries on a list (2.6); narcotic or psychotropic products (3.1.1); POM (4.1)

   Product families, as the supplier names them: Flower & Extracted Oils for CBPMs (own site) · Little Green Pharma (LGP) imported flower (two-year supply agreement announced 2 May 2023 — may have lapsed)

   Scottish cultivator. Own products page still says the company 'is currently undergoing its application to the U.K. regulators for the appropriate licences'; the MHRA registers nonetheless show MS 54236 and WDA(H) 54236 in force. The Home Office statement comes from trade press quoting the company, not from the company's own site.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

6. Internode Pharma (Aurora Cannabis UK importer)

   Internode Pharma Ltd · Companies House 15225062

   Anchored to: MHRA UK WDA(H) 58825

   WDA(H): Annex 1: medicinal products with (1.1) and without (1.2) a UK authorisation; procurement, holding, supply (2.1–2.3); products imported from countries on a list (2.6); narcotic or psychotropic products (3.1.1); POM and P categories (4.1, 4.4). Site: Unit 32, Fountain Business Park, Fountain Lane, Oldbury B69 3BH

   Aurora Cannabis announced (19–21 Aug 2026) the acquisition of Internode Pharma Limited ('a medical cannabis importer and wholesaler') and HAP Pharma Limited to obtain 'a direct route to the patient' in the UK; the announcement names no Aurora product families for the UK and trade press notes Internode had minimal trading activity to March 2026. Included because the WDA(H) anchor is confirmed; the Aurora attribution rests on the acquisition announcement. No MS licence found.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

7. IPS Pharma / IPS Specials

   Vertical Pharma Resources Limited · Companies House 06077026

   Anchored to: MHRA MS 32879 · UK MIA(IMP) 32879 · UK WDA(H) 32879

   MS: Non-sterile capsules, liquids for external/internal use, other solid dosage forms, semi-solids, suppositories, tablets; manufacture of herbal products (1.4.1.1); primary packing incl. transdermal patches; secondary packing; QC testing; importation (2.1). Site: 41 Central Avenue, West Molesey KT8 2QZ; nine contract labs · MIA(IMP): Manufacturer's/importer's authorisation for investigational medicinal products (legal basis: Investigational) · WDA(H): Annex 1: medicinal products with and without a UK authorisation (1.1, 1.2); procurement, holding, supply, export (2.1–2.4); products imported from countries on a list (2.6); narcotic or psychotropic products (3.1.1); cold chain (3.3); POM, GSL, P categories (4.1, 4.2, 4.4)

   Product families, as the supplier names them: Puro organic, sun-grown, live-dried flower (import agreement; first UK delivery reported 31 Mar 2026) · Plant-derived dronabinol 'WaterClear THC' (Dunbar Pharma API) supplied 'as part of our Specials service' in capsule, spray and dropper-solution forms (20 Aug 2026) · SOMAÍ Pharmaceuticals portfolio via the Grow Pharma joint venture (12 Mar 2024)

   Legal entity and company number confirmed on the privacy policy. Also a GPhC-registered pharmacy (1103485). Site mentions holding a 'Wholesalers Distribution Authorisation (Human) license' without quoting the number.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

8. PLF Pharma (Hempire Limited)

   Hempire Limited (t/a PLF Pharma) · Companies House 09319869

   Anchored to: MHRA MS 48809 · UK WDA(H) 48809

   MS: Importation only (2.1). Site: Promised Land Farm, Crank Road, St Helens WA11 8RW · WDA(H): Annex 1: medicinal products without a UK authorisation, intended (1.2) and not intended (1.3) for the UK market; procurement, holding, supply, export (2.1–2.4); narcotic or psychotropic products (3.1.1); POM, GSL, P (4.1, 4.2, 4.4)

   Own site: 'PLF Pharma is the trading name for Hempire Limited'. Site refers to 'medical cannabis products' and 'cannabis-based medicinal products' but names no product families; brand-level product listings exist only on third-party menu sites and are not recorded.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

9. Target Healthcare

   Target Healthcare Limited · Companies House SC431859

   Anchored to: MHRA MS 43086 · UK MIA 43086 · UK MIA(IMP) 43086 · UK WDA(H) 43086

   MS: Sites: Luton LU1 1UU and Hobson NE16 6EA. Non-sterile capsules (hard/soft shell), liquids, other solid dosage forms, pressurised preparations, semi-solids, suppositories; manufacture of herbal products (1.4.1.1); primary/secondary packing; QC testing; importation (2.1) · MIA: Manufacturer's/importer's authorisation, medicinal products for human use (legal basis: Human) · MIA(IMP): Manufacturer's/importer's authorisation for investigational medicinal products (legal basis: Investigational) · WDA(H): Annex 1: medicinal products with and without a UK authorisation (1.1, 1.2); procurement, holding, supply, export (2.1–2.4); products imported from countries on a list (2.6); narcotic or psychotropic products (3.1.1); cold chain (3.3); POM, GSL, P categories (4.1, 4.2, 4.4) — sites incl. Luton, Hobson (Newcastle) and East Kilbride

   Own site lists 'cannabis-based medicinal products' among its services ('early access and named patient programs, patient dispensing, cannabis-based medicinal products, and Specials repackaging') but names no product families. Its pharmacy arm (Target Pharmacy, GPhC 9012393) is in the pharmacies dataset. Mentions supplying 'controlled drug pharmaceuticals' without a Home Office licence number.

   An informative entry, not advertising and not a recommendation. We have no commercial relationship with this company and were not asked to list it.

   MHRA-licensed

Brands with no UK licence of their own

These names appear on clinic menus and in patient forums. None holds an MHRA licence in its own name; where a UK importer states the relationship, the brand is recorded under that importer above.

• Bedrocan — Dutch producer; no UK MHRA licence in its own name. Bedrocan's availability page lists the UK without naming an importer; third-party sources name Grow Pharma as UK distributor, which is not a first-party statement.
• Aurora Cannabis (brand) — No UK licence in Aurora's name; its UK route is the acquired importer Internode Pharma Ltd (listed). No Aurora UK product families named in the announcement.
• Adven (Curaleaf International brand) — No UK document naming Adven's UK importer/manufacturer was found; Curaleaf's UK licensed entity Rokshaw Limited is listed with the product family the MHRA has named.
• Khiron / Zerenia — No entry under 'Khiron' or 'Zerenia' in MHRA-GMDP (WDA(H)/MIA) or the gov.uk MS register.
• Althea — No entry under 'Althea' in MHRA-GMDP or the MS register; named only as a sourced brand by pharmacies.
• Tilray Medical — No entry under 'Tilray' or 'Lyphe' in MHRA-GMDP or the MS register (Tilray Lyphe UK Ltd, CH 17146093, incorporated April 2026, holds no listed licence). Historic distribution via Grow Pharma is recorded under Grow Group UK Limited.
• Spectrum Therapeutics (Canopy Growth) — No MHRA licence found; 'Spectrum Biomedical UK' and 'SpectrumX Direct' in the registers are unrelated companies.
• Cellen — No entry under 'Cellen' in MHRA-GMDP or the MS register.
• Little Green Pharma — No UK licence in its own name; imported by Hilltop Leaf under a 2023 agreement (recorded under Hilltop Leaf).
• Noidecs — Brand of the former Lyphe Group (Lyphe Group Limited dissolved 17 Feb 2026); no current MHRA licence holder identified for the brand.
• Bod (Bod Australia) — No entry under 'Bod' in MHRA-GMDP or the MS register.
• Ilios — No entry under 'Ilios' in MHRA-GMDP or the MS register.
• Cannaray — No entry under 'Cannaray' in MHRA-GMDP or the MS register.
• Medicann — No entry in MHRA-GMDP or the MS register; Medcann Pharma Ltd (London) is a pharmacy, not a licensed importer.
• Glass Pharms, Celadon Pharmaceuticals, Dalgety, Avida Medical, Lumir — UK-associated cultivators/brands with no matching holder in MHRA-GMDP or the MS register at the check date.
• SOMAÍ Pharmaceuticals, Puro, Organigram, Pure Sunfarms, The Green Organic Dutchman, Fraser Valley, Qwest — Foreign producers without UK licences; recorded as product families under their stated UK importers (Grow/IPS, IPS, 4C Labs).
• Xeal Pharma Ltd, Therismos Limited, Smartway Pharmaceuticals Limited, PCCA Limited, Mamedica Dispensary Limited, Specials Pharma Ltd — Hold MS and/or WDA(H) licences (46688, 40102, 42332, 17661, 57567, 53359) but their own sites name no CBPM product families they supply; recorded in the pharmacies dataset where applicable.

Source: MHRA-GMDP — manufacturer's and wholesale dealer's licences (plus the gov.uk MS register CSV for manufacturer's 'specials' licences) · read 7 September 2026